Partnership to improve access to contraception
The British Government joins new international partnership aiming to increase contraceptive access for 27 million women and girls in developing countries.
The partnership, launched at the United Nations on the 26 September, intends to provide a new contraceptive device called Jadelle to some of the poorest women and girls around the globe.
Jadelle consists of two small, thin silicone rods that are inserted into the upper arm where they release a synthetic progestin into the bloodstream, preventing pregnancy for up to five years.
As well as the UK, the Clinton Global Health Initiative, the US, Norway, and Bayer Healthcare AG are some of the other partners involved.
Bayer has agreed to cut the $18 price tag of the contraceptive device by at least half, on the condition that the partnership purchase at least 27 million devices between 2013 and 2018.
The contraceptive will be distributed in countries that are least likely to meet the Millennium Development Goal (MDG5) in improving maternal health and reducing the number of child deaths by 2015.
Currently more than 200 million women and girls who do not want to get pregnant have no access to modern contraceptives and family planning services.
The World Health Organisation estimate that maternal deaths could be cut by one third if all women wishing to use effective contraception had access to it.
When fully implemented, the partnership will avert more than 280,000 child and 30,000 maternal deaths due to improved spacing of pregnancies and avoiding other complications such as pre-term births.
This is the second partnership focusing on increasing access to contraceptive devices to be announced in the past six months. A similar effort by the Bill and Melinda Gates Foundation, the UK, the US, USAID, UNFPA and Pfizer was unveiled at the London Summit on Family Planning held in July.











